Basit öğe kaydını göster

The effects of Buprenorphine/Naloxane Maintenance Treatment on the Quality of Life, Substance Use and Functionality in Opiate Dependence: A Follow-Up Study

dc.contributor.authorBolek, Selahattin
dc.contributor.authorEkinci, Okan
dc.contributor.authorYargic, Ilhan
dc.date.accessioned2021-03-05T20:49:27Z
dc.date.available2021-03-05T20:49:27Z
dc.date.issued2016
dc.identifier.citationBolek S., Yargic I., Ekinci O., "The effects of Buprenorphine/Naloxane Maintenance Treatment on the Quality of Life, Substance Use and Functionality in Opiate Dependence: A Follow-Up Study", KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.26, ss.141-151, 2016
dc.identifier.issn1017-7833
dc.identifier.otherav_d5fb0bc6-ef5c-4ee3-9b26-e283ca65383d
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/141223
dc.identifier.urihttps://doi.org/10.5455/bcp.20151101022909
dc.description.abstractObjective: Abstinance is not the only goal of the current drug addiction treatment modalities. New modalities focus rather on improvement in physical and mental health, personal and social functionality. It has been found that opioid maintanence treatment reduces the rates of illicit drug use, crime and sexual transmitted diseases in addition to increasing psychiatric, somatic and social functionality. In this study, we examined the effects of Buprenorphine/Naloxane (BN) maintenance treatment on substance abuse, quality of life and functionality.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectTemel Eczacılık Bilimleri
dc.subjectEczacılık
dc.subjectKlinik Tıp (MED)
dc.subjectPsikiyatri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleThe effects of Buprenorphine/Naloxane Maintenance Treatment on the Quality of Life, Substance Use and Functionality in Opiate Dependence: A Follow-Up Study
dc.typeMakale
dc.relation.journalKLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
dc.contributor.departmentTarsus State Hosp , ,
dc.identifier.volume26
dc.identifier.issue2
dc.identifier.startpage141
dc.identifier.endpage151
dc.contributor.firstauthorID232874


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster